RT @NEJM: Original Article: Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA (POINT) https://t.co/pL4TKYgHgK Editorial:…
RT @ClayDellMed: And the results are out: Clopidogrel-aspirin reduces major ischemic events after minor stroke/TIA but with some increase…
RT @NEJM: Original Article: Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA (POINT) https://t.co/pL4TKYgHgK Editorial:…
Why not DOAC here? Feels like lost opportunity to compare third arm. Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA | NEJM https://t.co/ROq6c1af3n
RT @NEJM: Original Article: Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA (POINT) https://t.co/pL4TKYgHgK Editorial:…
RT @ClayDellMed: And the results are out: Clopidogrel-aspirin reduces major ischemic events after minor stroke/TIA but with some increase…
RT @NEJM: Original Article: Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA (POINT) https://t.co/pL4TKYgHgK Editorial:…
Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA | NEJM https://t.co/7mAJMkBd3W
RT @NEJM: Original Article: Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA (POINT) https://t.co/pL4TKYgHgK Editorial:…
RT @NEJM: Original Article: Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA (POINT) https://t.co/pL4TKYgHgK Editorial:…
RT @NEJM: Original Article: Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA (POINT) https://t.co/pL4TKYgHgK Editorial:…
RT @pascualpinera: A tener en cuenta:In patients with minor ischemic stroke or high-risk TIA,those who received combination of clopidogrel…
RT @JulianOwenEM_CC: Bottom line for me is use ASA alone. Not sure I agree with the editorial. Assuming bleeding risk will be lower by alte…
Nice editorial 👍🏻: DAPT reduced rates of ischemic stroke in weeks following high risk TIA, offset by higher bleeding later on that may be related to longer treatment period w DAPT (90 days vs 21 days in CHANCE) https://t.co/4Z9imWPsbZ
However, DAPT appears to have value in the short term 2-3 wk high-risk period after the TIA, before the peak of systemic increased bleeding occurs. https://t.co/eanpKQCgyX
RT @NEJM: Original Article: Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA (POINT) https://t.co/pL4TKYgHgK Editorial:…
RT @NEJM: Original Article: Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA (POINT) https://t.co/pL4TKYgHgK Editorial:…
The balance of ischemic reduction and bleeding risk still evident in 2018 https://t.co/TrjvmbgfJq
Bottom line for me is use ASA alone. Not sure I agree with the editorial. Assuming bleeding risk will be lower by altering trial conditions (limiting duration of clopidogrel) is hypothesis generating only. https://t.co/4xWlYHBnLu
RT @NEJM: Original Article: Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA (POINT) https://t.co/pL4TKYgHgK Editorial:…
RT @cpcannon: Benefit of clopidogrel + aspirin for acute TIA or stroke. Just as in UA/NSTEMI and STEMI - benefit seen. https://t.co/ex5AgM…
RT @NEJM: Original Article: Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA (POINT) https://t.co/pL4TKYgHgK Editorial:…
RT @NEJM: Original Article: Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA (POINT) https://t.co/pL4TKYgHgK Editorial:…
Agreed. Worth for the most part #pointtrial https://t.co/jdvI0tBL1R
RT @NEJM: Original Article: Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA (POINT) https://t.co/pL4TKYgHgK Editorial:…
RT @NEJM: Original Article: Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA (POINT) https://t.co/pL4TKYgHgK Editorial:…
POINT trial is out! https://t.co/GFxoigw4Kn
RT @NEJM: Original Article: Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA (POINT) https://t.co/pL4TKYgHgK Editorial:…
RT @NEJM: Original Article: Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA (POINT) https://t.co/pL4TKYgHgK Editorial:…
RT @NEJM: Original Article: Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA (POINT) https://t.co/pL4TKYgHgK Editorial:…
RT @NEJM: Original Article: Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA (POINT) https://t.co/pL4TKYgHgK Editorial:…
RT @NEJM: Original Article: Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA (POINT) https://t.co/pL4TKYgHgK Editorial:…
RT @NEJM: Original Article: Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA (POINT) https://t.co/pL4TKYgHgK Editorial:…
RT @NEJM: Original Article: Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA (POINT) https://t.co/pL4TKYgHgK Editorial:…
RT @NEJM: Original Article: Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA (POINT) https://t.co/pL4TKYgHgK Editorial:…
RT @NEJM: Original Article: Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA (POINT) https://t.co/pL4TKYgHgK Editorial:…
RT @NEJM: Original Article: Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA (POINT) https://t.co/pL4TKYgHgK Editorial:…
RT @ClayDellMed: And the results are out: Clopidogrel-aspirin reduces major ischemic events after minor stroke/TIA but with some increase…
RT @NEJM: Original Article: Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA (POINT) https://t.co/pL4TKYgHgK Editorial:…
RT @NEJM: Original Article: Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA (POINT) https://t.co/pL4TKYgHgK Editorial:…
RT @NEJM: Original Article: Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA (POINT) https://t.co/pL4TKYgHgK Editorial:…
RT @NEJM: Original Article: Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA (POINT) https://t.co/pL4TKYgHgK Editorial:…
Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA | NEJM https://t.co/kRJdlzDcYR
RT @NEJM: Original Article: Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA (POINT) https://t.co/pL4TKYgHgK Editorial:…
RT @NEJM: Original Article: Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA (POINT) https://t.co/pL4TKYgHgK Editorial:…
RT @NEJM: Original Article: Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA (POINT) https://t.co/pL4TKYgHgK Editorial:…
RT @NEJM: Original Article: Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA (POINT) https://t.co/pL4TKYgHgK Editorial:…
Asa/clopidogrel in minor stroke/high risk TIA as a sort of extrapolation of the CHANCE trial to the general population. Major ichemic events reduced but hemorrhage increased. NNT to prevent one major ischemic event approx 67, NNH approx 200. https://t.co/r
RT @NEJM: Original Article: Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA (POINT) https://t.co/pL4TKYgHgK Editorial:…
RT @ClayDellMed: And the results are out: Clopidogrel-aspirin reduces major ischemic events after minor stroke/TIA but with some increase…
Acute Ischemic Stoke https://t.co/VZQt9zcy1D
RT @NEJM: Original Article: Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA (POINT) https://t.co/pL4TKYgHgK Editorial:…
RT @pascualpinera: A tener en cuenta:In patients with minor ischemic stroke or high-risk TIA,those who received combination of clopidogrel…
RT @NEJM: Original Article: Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA (POINT) https://t.co/pL4TKYgHgK Editorial:…
RT @ClayDellMed: And the results are out: Clopidogrel-aspirin reduces major ischemic events after minor stroke/TIA but with some increase…
RT @ClayDellMed: And the results are out: Clopidogrel-aspirin reduces major ischemic events after minor stroke/TIA but with some increase…
RT @NEJM: Original Article: Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA (POINT) https://t.co/pL4TKYgHgK Editorial:…
And the results are out: Clopidogrel-aspirin reduces major ischemic events after minor stroke/TIA but with some increase in major hemorrhage. For 1000 treated, 15 major ischemic events are prevented and 5 major hemorrhages produced. Worth it for most...
Big study with big results @NEJM for #stroke management https://t.co/AJMUJziPA3
RT @NEJM: Original Article: Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA (POINT) https://t.co/pL4TKYgHgK Editorial:…
RT @NEJM: Original Article: Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA (POINT) https://t.co/pL4TKYgHgK Editorial:…
RT @NEJM: Original Article: Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA (POINT) https://t.co/pL4TKYgHgK Editorial:…
RT @NEJM: Original Article: Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA (POINT) https://t.co/pL4TKYgHgK Editorial:…
RT @NEJM: Original Article: Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA (POINT) https://t.co/pL4TKYgHgK Editorial:…
RT @NEJM: Original Article: Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA (POINT) https://t.co/pL4TKYgHgK Editorial:…
Benefit of clopidogrel + aspirin for acute TIA or stroke. Just as in UA/NSTEMI and STEMI - benefit seen. https://t.co/ex5AgMAA6t https://t.co/20muBtYVDv
RT @NEJM: Original Article: Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA (POINT) https://t.co/pL4TKYgHgK Editorial:…
POINT trial results comparing #Clopidogrel and #aspirin vs aspirin alone in patients with minor ischemic #stroke or high risk TIA https://t.co/BjKqrw9fRt
RT @NEJM: Original Article: Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA (POINT) https://t.co/pL4TKYgHgK Editorial:…
“In patients with minor ischemic #stroke or high-risk #TIA , those who received a combination of #clopidogrel and #aspirin had a lower risk of major ischemic events but a higher risk of major hemorrhage at 90 days than those who received aspirin alone.” ht
F/U to CHANCE published. In patients with ischemic stroke/TIA, ASA + clopidogrel for first 90 days reduces MACE (mainly driven by stroke reduction, ARR 1.5%) vs. ASA alone, but increase in major hemorrhage (mainly non-ICH bleeding, absolute risk increase
RT @NEJM: Original Article: Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA (POINT) https://t.co/pL4TKYgHgK Editorial:…
RT @NEJM: Original Article: Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA (POINT) https://t.co/pL4TKYgHgK Editorial:…
RT @NEJM: Original Article: Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA (POINT) https://t.co/pL4TKYgHgK Editorial:…
RT @NEJM: Original Article: Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA (POINT) https://t.co/pL4TKYgHgK Editorial:…
RT @NEJM: Original Article: Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA (POINT) https://t.co/pL4TKYgHgK Editorial:…
Sigue cumpliéndose la máxima observada en otros territorios vasculares: A mayor intensidad del tratamiento antiagregante menos eventos isquémicos pero a expensas de una mayor tasa de sangrados https://t.co/VTzYhJhf7b
RT @NEJM: Original Article: Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA (POINT) https://t.co/pL4TKYgHgK Editorial:…
Muy interesante. Doble antiagregación tras AIT. @Diaz88A https://t.co/3qiDHCuj07
RT @NEJM: Original Article: Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA (POINT) https://t.co/pL4TKYgHgK Editorial:…
RT @pascualpinera: A tener en cuenta:In patients with minor ischemic stroke or high-risk TIA,those who received combination of clopidogrel…
A tener en cuenta:In patients with minor ischemic stroke or high-risk TIA,those who received combination of clopidogrel and aspirin had a lower risk of major ischemic events but a higher risk of major hemorrhage at 90d than those who received aspirin alone
RT @NEJM: Original Article: Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA (POINT) https://t.co/pL4TKYgHgK Editorial:…
RT @NEJM: Original Article: Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA (POINT) https://t.co/pL4TKYgHgK Editorial:…
RT @NEJM: Original Article: Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA (POINT) https://t.co/pL4TKYgHgK Editorial:…
RT @NEJM: Original Article: Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA (POINT) https://t.co/pL4TKYgHgK Editorial:…
RT @NEJM: Original Article: Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA (POINT) https://t.co/pL4TKYgHgK Editorial:…
RT @StrokePrevent: WAKE-UP and POINT trials are presented at #ESOC2018 and published in New England Journal #NEJM. POINT - 25% relative ris…
RT @NEJM: Original Article: Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA (POINT) https://t.co/pL4TKYgHgK Editorial:…
RT @NEJM: Original Article: Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA (POINT) https://t.co/pL4TKYgHgK Editorial:…
RT @NEJM: Original Article: Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA (POINT) https://t.co/pL4TKYgHgK Editorial:…
RT @NEJM: Original Article: Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA (POINT) https://t.co/pL4TKYgHgK Editorial:…
RT @NEJM: Original Article: Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA (POINT) https://t.co/pL4TKYgHgK Editorial:…
RT @NEJM: Original Article: Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA (POINT) https://t.co/pL4TKYgHgK Editorial:…
Original Article: Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA (POINT) https://t.co/pL4TKYgHgK Editorial: Antiplatelet Therapy after Ischemic Stroke or TIA https://t.co/sZytrPJ2LS #ESOC2018 https://t.co/EzMqtoqccl
RT @fniainle: Clopidogrel +Aspirin in Acute Ischemic Stroke and High-Risk TIA- lower recurrence risk but higher major bleeding risk NEJM h…
The balance between clotting and bleeding is evidently balanced in TIA / stroke with DAPT https://t.co/Y9kffCxBxz
RT @DomingoPascualF: Clopidogrel + AAS superior a solo AAS en prevención de ACV tras AIT, sobre todo en periodo inicial @NEJM https://t.co/…
Clopidogrel +Aspirin in Acute Ischemic Stroke and High-Risk TIA- lower recurrence risk but higher major bleeding risk NEJM https://t.co/v2PLPz27vX